Chattem Company Profile

What is the competitive landscape for CHATTEM, and when can generic versions of CHATTEM drugs launch?

CHATTEM has twenty approved drugs.

There are two US patents protecting CHATTEM drugs.

There are sixty-seven patent family members on CHATTEM drugs in forty countries and two supplementary protection certificates in two countries.

Summary for Chattem

International Patents:	67
US Patents:	2
Tradenames:	17
Ingredients:	9
NDAs:	20

Drugs and US Patents for Chattem

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chattem Sanofi	ALLEGRA ALLERGY	fexofenadine hydrochloride	TABLET;ORAL	020872-010	Jan 24, 2011		OTC	Yes	Yes
Chattem Sanofi	ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION	fexofenadine hydrochloride; pseudoephedrine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021704-002	Jan 24, 2011		OTC	Yes	Yes
Chattem Sanofi	CHILDREN'S ALLEGRA HIVES	fexofenadine hydrochloride	SUSPENSION;ORAL	201373-002	Jan 24, 2011		DISCN	Yes	No	8,933,097		Y
Chattem Sanofi	NICODERM CQ	nicotine	FILM, EXTENDED RELEASE;TRANSDERMAL	020165-006	Aug 2, 1996		OTC	Yes	No
Chattem Sanofi	ALLEGRA	fexofenadine hydrochloride	CAPSULE;ORAL	020625-001	Jul 25, 1996		DISCN	No	No
Chattem Sanofi	XYZAL ALLERGY 24HR	levocetirizine dihydrochloride	TABLET;ORAL	209089-001	Jan 31, 2017		OTC	Yes	Yes

Expired US Patents for Chattem

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Chattem Sanofi	ALLEGRA ALLERGY	fexofenadine hydrochloride	TABLET;ORAL	020872-007	Jan 24, 2011	7,135,571*PED
Chattem Sanofi	ALLEGRA HIVES	fexofenadine hydrochloride	TABLET;ORAL	020872-009	Jan 24, 2011	7,138,524*PED
Chattem Sanofi	ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION	fexofenadine hydrochloride; pseudoephedrine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	020786-002	Jan 24, 2011	5,855,912*PED
Chattem Sanofi	NICODERM CQ	nicotine	FILM, EXTENDED RELEASE;TRANSDERMAL	020165-004	Aug 2, 1996	8,663,680
Chattem Sanofi	CHILDREN'S ALLEGRA HIVES	fexofenadine hydrochloride	TABLET, ORALLY DISINTEGRATING;ORAL	021909-003	Jan 24, 2011	6,187,791
Chattem Sanofi	CHILDREN'S ALLEGRA ALLERGY	fexofenadine hydrochloride	TABLET, ORALLY DISINTEGRATING;ORAL	021909-002	Jan 24, 2011	7,138,524

Paragraph IV (Patent) Challenges for CHATTEM drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Transdermal System	7 mg/24 hrs, 14 mg/24 hrs, and 21 mg/24 hrs		2014-05-30
	Tablets	5 mg		2007-12-17
	Oral Suspension	30 mg/5 mL		2010-01-25
	Oral Solution	0.5 mg/mL		2009-01-14
	Tablets	150 mg		2007-10-30

International Patents for Chattem Drugs

Country	Patent Number	Estimated Expiration
China	101316580
South Korea	20070043841
Hong Kong	1103958
Eurasian Patent Organization	012463
Austria	E431137
Peru	20071003

Supplementary Protection Certificates for Chattem Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0663828	C300085	Netherlands		PRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103
0058146	2001C/045	Belgium		PRODUCT NAME: DICHLORHYDRATE DE LEVOCETIRIZINE; NAT RER. NO/DATE: 194 IS 90 F3 20011022; FIRST REG.: DE 49903.00.00 20010103

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Chattem
• Chattem Sanofi